Free Trial

CareTrust REIT (NYSE:CTRE) Stock Price Target Lowered at KeyCorp

CareTrust REIT logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • KeyCorp lowered its CareTrust REIT price target from $46 to $43 while maintaining an “overweight” rating; the new target implies about 13% upside from the prior close.
  • Analyst sentiment remains broadly positive: MarketBeat reports a “Moderate Buy” consensus and an average price target of $43.50.
  • CareTrust reported quarterly EPS of $0.35, below the $0.52 analyst consensus, on revenue of $176.36 million.
  • Interested in CareTrust REIT? Here are five stocks we like better.

CareTrust REIT (NYSE:CTRE - Get Free Report) had its price target dropped by KeyCorp from $46.00 to $43.00 in a report released on Monday, Benzinga reports. The firm currently has an "overweight" rating on the stock. KeyCorp's price target indicates a potential upside of 12.98% from the company's previous close.

CTRE has been the subject of a number of other reports. Raymond James Financial reaffirmed an "outperform" rating and set a $41.00 price objective on shares of CareTrust REIT in a research report on Tuesday, November 10th. Huntington began coverage on shares of CareTrust REIT in a research report on Thursday, September 10th. They issued an "outperform" rating and a $44.00 price objective on the stock. Wells Fargo & Company cut their target price on shares of CareTrust REIT from $44.00 to $43.00 and set an "overweight" rating for the company in a research note on Monday, October 19th. Weiss Ratings downgraded shares of CareTrust REIT from a "buy (b+)" rating to a "buy (b)" rating in a report on Monday, October 12th. Finally, Citigroup reiterated a "market outperform" rating on shares of CareTrust REIT in a research note on Tuesday, October 13th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, CareTrust REIT presently has a consensus rating of "Moderate Buy" and an average price target of $43.50.

Read Our Latest Stock Report on CareTrust REIT

CareTrust REIT Stock Performance

CTRE opened at $38.06 on Monday. The company has a quick ratio of 3.08, a current ratio of 3.08 and a debt-to-equity ratio of 0.39. CareTrust REIT has a 12-month low of $34.74 and a 12-month high of $43.62. The business has a 50 day moving average of $37.19 and a 200-day moving average of $39.02. The stock has a market cap of $9.81 billion, a price-to-earnings ratio of 23.94 and a beta of 0.77.

CareTrust REIT (NYSE:CTRE - Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported $0.35 earnings per share for the quarter, missing analysts' consensus estimates of $0.52 by ($0.17). CareTrust REIT had a return on equity of 8.08% and a net margin of 59.18%. The business had revenue of $176.36 million for the quarter. On average, equities research analysts expect that CareTrust REIT will post 2.08 earnings per share for the current year.

Institutional Investors Weigh In On CareTrust REIT

A number of hedge funds and other institutional investors have recently modified their holdings of CTRE. BlackRock Inc. acquired a new stake in shares of CareTrust REIT in the second quarter valued at approximately $1,643,290,000. Deutsche Bank AG bought a new stake in shares of CareTrust REIT in the second quarter valued at approximately $143,963,000. Bank of New York Mellon Corp acquired a new stake in CareTrust REIT during the second quarter worth approximately $102,162,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in CareTrust REIT by 35,170.9% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,411,896 shares of the company's stock worth $56,970,000 after buying an additional 1,407,893 shares in the last quarter. Finally, Legal & General Group Plc acquired a new stake in CareTrust REIT during the second quarter worth approximately $46,866,000. Institutional investors and hedge funds own 87.77% of the company's stock.

CareTrust REIT Company Profile

(Get Free Report)

CareTrust REIT, Inc. is a real estate investment trust that owns and invests in healthcare-related properties, with a focus on skilled nursing facilities and senior housing. Its portfolio also includes assisted living and other properties that serve older adults and people requiring healthcare services. The company primarily works with healthcare operators through long-term property leases and other real estate investments. CareTrust's properties are located across the United States, and the company has expanded its investments into the United Kingdom.

Further Reading

Analyst Recommendations for CareTrust REIT (NYSE:CTRE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CareTrust REIT Right Now?

Before you consider CareTrust REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CareTrust REIT wasn't on the list.

While CareTrust REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines